Dali Pharmaceutical Co. Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 294.324 million compared to CNY 401.483 million a year ago. Operating income was CNY 15.954 million compared to CNY 11.621 million a year ago. Net income was CNY 13.505 million compared to CNY 10.700 million a year ago. Basic earnings per share from continuing operations was CNY 0.08 compared to CNY 0.06 a year ago.